Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 11;12(24):7614.
doi: 10.3390/jcm12247614.

The Seattle Heart Failure Model in Kidney Transplant Recipients

Affiliations

The Seattle Heart Failure Model in Kidney Transplant Recipients

Angelica Perez-Gutierrez et al. J Clin Med. .

Abstract

Cardiovascular disease is the leading cause of mortality following kidney transplantation. Heart failure affects 17-21% of patients with chronic kidney disease and increases along with time receiving dialysis. The Seattle Heart Failure Model (SHFM) is a validated mortality risk model for heart failure patients that incorporates clinical, therapeutic, and laboratory parameters but does not include measures of kidney function. We applied the SHFM to patients with end-stage renal disease (ESRD) who were being evaluated for kidney transplantation to determine if the model was associated with post-transplant mortality. This retrospective single-center study analyzed survival among 360 adult deceased-donor kidney transplant recipients. Cox regression was used to model post-transplant patient survival. Our findings indicated that a 1.0-point increase in the adapted SHFM score was significantly associated with post-transplant mortality (HR 1.76, 95% CI = 1.10-2.83, p = 0.02), independently of the Kidney Donor Profile Index and Estimated Post-Transplant Survival. Individual covariates of the SHFM were evaluated in univariate analyses, and age, sodium, cholesterol, and lymphocyte count were significantly related to mortality. This study provides preliminary evidence that an adapted SHFM score could be a useful tool in evaluating mortality risk post-transplant in patients with ESRD.

Keywords: Seattle Heart Failure Model; cardiac risk; kidney transplant; mortality.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Prediction nomogram for 2-year and 5-year patient survival, using the adapted Seattle Heart Failure Model (SHFM), Kidney Donor Profile Index (KDPI), and Expected Post-Transplant Survival (EPTS) scores.
Figure 2
Figure 2
Predicted two and five-year survival according to the Seattle Heart Failure Model (SHFM) for heart failure patients and kidney transplant candidates.

References

    1. United States Renal Data 2018 USRDS annual report: Epidemiology of kidney disease in the United States. Am. J. Kidney Dis. 2019;73((Suppl. S1)):A7–A8. doi: 10.1053/j.ajkd.2019.01.001. - DOI - PMC - PubMed
    1. Awan A.A., Niu J., Pan J.S., Erickson K.F., Mandayam S., Winkelmayer W.C., Navaneethan S.D., Ramanathan V. Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996–2014) Am. J. Nephrol. 2018;48:472–481. doi: 10.1159/000495081. - DOI - PMC - PubMed
    1. Gansevoort R.T., Correa-Rotter R., Hemmelgarn B.R., Jafar T.H., Heerspink H.J.L., Mann J.F., Matsushita K., Wen C.P. Chronic kidney disease and cardiovascular risk: Epidemiology, mechanisms, and prevention. Lancet. 2013;382:339–352. doi: 10.1016/S0140-6736(13)60595-4. - DOI - PubMed
    1. Kottgen A., Russell S.D., Loehr L.R., Crainiceanu C.M., Rosamond W.D., Chang P.P., Chambless L.E., Coresh J. Reduced Kidney Function as a Risk Factor for Incident Heart Failure: The Atherosclerosis Risk in Communities (ARIC) Study. J. Am. Soc. Nephrol. 2007;18:1307–1315. doi: 10.1681/ASN.2006101159. - DOI - PubMed
    1. House A.A., Wanner C., Sarnak M.J., Piña I.L., McIntyre C.W., Komenda P., Kasiske B.L., Deswal A., de Filippi C.R., Cleland J.G.F., et al. Heart failure in chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019;95:1304–1317. doi: 10.1016/j.kint.2019.02.022. - DOI - PubMed

LinkOut - more resources